Related Experiment Videos

[High sensitivity C reactive protein and lipid status as a risk factors for coronary disease]

Jasmina Nurkić1, Mahmud Nurkić, Midhat Nurkić

  • 1Odjeljenje za imunologiju Zavoda za mikrobiologiju, Poliklinika za laboratorijsku dijagnostiku, UKC Tuzla. jnurki@yahoo.com

Medicinski Arhiv
|February 1, 2008
PubMed

Insights

High-sensitivity C-reactive protein (hsCRP) levels are elevated in patients with significant coronary artery disease (CAD). Elevated hsCRP, above 3.0 mg/dL, better predicts CAD than traditional lipid profiles.

Area of Science:

  • Cardiology
  • Biochemistry
  • Inflammation research

Context:

  • Inflammation plays a key role in atherosclerosis and acute coronary syndrome (ACS).
  • High-sensitivity C-reactive protein (hsCRP) is an independent risk factor for cardiovascular disease.
  • Oxidized low-density lipoprotein (oxLDL) contributes to atherogenesis.

Purpose:

  • To determine hsCRP values in patients with angiographically verified coronary artery disease (CAD).
  • To assess if hsCRP levels > 3.0 mg/dL are superior predictors of CAD compared to lipid status.
  • To evaluate the relationship between hsCRP, lipid profiles, and CAD severity.

Summary:

  • Patients with significant CAD (stenosis >70%) exhibited higher hsCRP levels than those without significant disease.
  • hsCRP values in CAD patients indicate intermediate to high risk for future cardiovascular events.
  • Elevated LDL and total cholesterol were observed in CAD patients, while higher HDL correlated with lower hsCRP in non-CAD patients.

Impact:

  • This study highlights hsCRP as a valuable biomarker for CAD detection and risk stratification.
  • Findings suggest hsCRP evaluation alongside lipid profiles can improve cardiovascular risk assessment.
  • Understanding the role of hsCRP in CAD may lead to improved diagnostic and therapeutic strategies.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...